MPIE: A state enterprise success story

With new facilities, imported equipment and foreign expertise, a state-owned enterprise is expanding its pharmaceutical business – and even moving into export markets. Pointing to a tablet-coating machine, a woman employee in protective clothing proudly notes that no other pharmaceutical maker in the country has such advanced equipment. “This is imported from Germany and is […]

FDA sues 25 pharmacies for selling fake medical products

Dr Than Htut said all the 25 pharmacies which were sued also did not have valid licenses to sell medicines and medical products. Last year, the FDA sued 99 pharmacies for the same violations. “It is big amount. Every township in Myanmar has substandard, falsified and illegal medical products entering the market,” he told reporters […]

Japan constitutes nearly half of FDI in Thilawa SEZ

Japan has put investments of US$468 million into Thilawa Special Economic Zone (SEZ) so far, accounting for over 43 per cent of total foreign direct investments, according to Myanmar Japan Thilawa Development Limited. Thailand was second with FDI of over $130 million. The manufacturing industry attained the highest FDI of over US$773million, followed by the […]

Myanmar pharma sector expected to grow 10-15%

MYANMAR’S pharmaceutical industry is expected to rev up 10-15 per cent a year thanks to the government’s increasing spending on healthcare. The Myanmar Pharmaceutical and Medical Equipment Entrepreneurs Association made the forecast at the recent “Myanmar Medi-Pharm Expo”, signalling confidence in the future of the nascent market now estimated to be worth about US$100 million […]

Indian Sun Pharma plans to open branch office in Myanmar

India-based Sun Pharmaceutical Industries Ltd (Sun Pharma), a global pharmaceutical company headquartered in Mumbai, is planning to open branch office and to expand its business in Myanmar, according to the reports. The Directorate of Investment and Companies Administration-DICA has already granted permission of Sun Pharma company registration (Interim) on July 30th to expend its pharmaceutical […]